Cargando…

Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews

Background Many meta-analyses contain only a small number of studies, which makes it difficult to estimate the extent of between-study heterogeneity. Bayesian meta-analysis allows incorporation of external evidence on heterogeneity, and offers advantages over conventional random-effects meta-analysi...

Descripción completa

Detalles Bibliográficos
Autores principales: Turner, Rebecca M, Davey, Jonathan, Clarke, Mike J, Thompson, Simon G, Higgins, Julian PT
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3396310/
https://www.ncbi.nlm.nih.gov/pubmed/22461129
http://dx.doi.org/10.1093/ije/dys041
_version_ 1782238097733320704
author Turner, Rebecca M
Davey, Jonathan
Clarke, Mike J
Thompson, Simon G
Higgins, Julian PT
author_facet Turner, Rebecca M
Davey, Jonathan
Clarke, Mike J
Thompson, Simon G
Higgins, Julian PT
author_sort Turner, Rebecca M
collection PubMed
description Background Many meta-analyses contain only a small number of studies, which makes it difficult to estimate the extent of between-study heterogeneity. Bayesian meta-analysis allows incorporation of external evidence on heterogeneity, and offers advantages over conventional random-effects meta-analysis. To assist in this, we provide empirical evidence on the likely extent of heterogeneity in particular areas of health care. Methods Our analyses included 14 886 meta-analyses from the Cochrane Database of Systematic Reviews. We classified each meta-analysis according to the type of outcome, type of intervention comparison and medical specialty. By modelling the study data from all meta-analyses simultaneously, using the log odds ratio scale, we investigated the impact of meta-analysis characteristics on the underlying between-study heterogeneity variance. Predictive distributions were obtained for the heterogeneity expected in future meta-analyses. Results Between-study heterogeneity variances for meta-analyses in which the outcome was all-cause mortality were found to be on average 17% (95% CI 10–26) of variances for other outcomes. In meta-analyses comparing two active pharmacological interventions, heterogeneity was on average 75% (95% CI 58–95) of variances for non-pharmacological interventions. Meta-analysis size was found to have only a small effect on heterogeneity. Predictive distributions are presented for nine different settings, defined by type of outcome and type of intervention comparison. For example, for a planned meta-analysis comparing a pharmacological intervention against placebo or control with a subjectively measured outcome, the predictive distribution for heterogeneity is a log-normal (−2.13, 1.58(2)) distribution, which has a median value of 0.12. In an example of meta-analysis of six studies, incorporating external evidence led to a smaller heterogeneity estimate and a narrower confidence interval for the combined intervention effect. Conclusions Meta-analysis characteristics were strongly associated with the degree of between-study heterogeneity, and predictive distributions for heterogeneity differed substantially across settings. The informative priors provided will be very beneficial in future meta-analyses including few studies.
format Online
Article
Text
id pubmed-3396310
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-33963102012-07-13 Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews Turner, Rebecca M Davey, Jonathan Clarke, Mike J Thompson, Simon G Higgins, Julian PT Int J Epidemiol Methodology Background Many meta-analyses contain only a small number of studies, which makes it difficult to estimate the extent of between-study heterogeneity. Bayesian meta-analysis allows incorporation of external evidence on heterogeneity, and offers advantages over conventional random-effects meta-analysis. To assist in this, we provide empirical evidence on the likely extent of heterogeneity in particular areas of health care. Methods Our analyses included 14 886 meta-analyses from the Cochrane Database of Systematic Reviews. We classified each meta-analysis according to the type of outcome, type of intervention comparison and medical specialty. By modelling the study data from all meta-analyses simultaneously, using the log odds ratio scale, we investigated the impact of meta-analysis characteristics on the underlying between-study heterogeneity variance. Predictive distributions were obtained for the heterogeneity expected in future meta-analyses. Results Between-study heterogeneity variances for meta-analyses in which the outcome was all-cause mortality were found to be on average 17% (95% CI 10–26) of variances for other outcomes. In meta-analyses comparing two active pharmacological interventions, heterogeneity was on average 75% (95% CI 58–95) of variances for non-pharmacological interventions. Meta-analysis size was found to have only a small effect on heterogeneity. Predictive distributions are presented for nine different settings, defined by type of outcome and type of intervention comparison. For example, for a planned meta-analysis comparing a pharmacological intervention against placebo or control with a subjectively measured outcome, the predictive distribution for heterogeneity is a log-normal (−2.13, 1.58(2)) distribution, which has a median value of 0.12. In an example of meta-analysis of six studies, incorporating external evidence led to a smaller heterogeneity estimate and a narrower confidence interval for the combined intervention effect. Conclusions Meta-analysis characteristics were strongly associated with the degree of between-study heterogeneity, and predictive distributions for heterogeneity differed substantially across settings. The informative priors provided will be very beneficial in future meta-analyses including few studies. Oxford University Press 2012-06 2012-03-29 /pmc/articles/PMC3396310/ /pubmed/22461129 http://dx.doi.org/10.1093/ije/dys041 Text en Published by Oxford University Press on behalf of the International Epidemiological Association © The Author 2012; all rights reserved. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Methodology
Turner, Rebecca M
Davey, Jonathan
Clarke, Mike J
Thompson, Simon G
Higgins, Julian PT
Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews
title Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews
title_full Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews
title_fullStr Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews
title_full_unstemmed Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews
title_short Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews
title_sort predicting the extent of heterogeneity in meta-analysis, using empirical data from the cochrane database of systematic reviews
topic Methodology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3396310/
https://www.ncbi.nlm.nih.gov/pubmed/22461129
http://dx.doi.org/10.1093/ije/dys041
work_keys_str_mv AT turnerrebeccam predictingtheextentofheterogeneityinmetaanalysisusingempiricaldatafromthecochranedatabaseofsystematicreviews
AT daveyjonathan predictingtheextentofheterogeneityinmetaanalysisusingempiricaldatafromthecochranedatabaseofsystematicreviews
AT clarkemikej predictingtheextentofheterogeneityinmetaanalysisusingempiricaldatafromthecochranedatabaseofsystematicreviews
AT thompsonsimong predictingtheextentofheterogeneityinmetaanalysisusingempiricaldatafromthecochranedatabaseofsystematicreviews
AT higginsjulianpt predictingtheextentofheterogeneityinmetaanalysisusingempiricaldatafromthecochranedatabaseofsystematicreviews